Semaglutide Seems Beneficial for Comorbid T2DM, Tobacco Use Disorder
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, July 29, 2024 -- For patients with type 2 diabetes mellitus (T2DM) and tobacco use disorder (TUD), new use of semaglutide is associated with lower risk of TUD-related health care measures compared with other antidiabetes medications, according to a study published online July 30 in the Annals of Internal Medicine.
William Wang, from the Case Western Reserve University School of Medicine in Cleveland, and colleagues examined the association of semaglutide with TUD-related health care measures in patients with comorbid T2DM and TUD in an emulation target trial. Seven target trials were emulated among eligible patients comparing the new use of semaglutide with seven other antidiabetes medications. The analyses included 222,942 new users of antidiabetes medications, of whom 5,967 were new users of semaglutide.
The researchers found that compared with other antidiabetes medications, semaglutide was associated with a significantly lower risk for medical encounters for TUD diagnosis, with the strongest association compared with insulins (hazard ratio, 0.68) and the weakest, but statistically significant, association compared with other glucagon-like peptide 1 receptor agonist medications (hazard ratio, 0.88). Reduced smoking cessation medication prescription and reduced counseling were seen in association with semaglutide. Patients with and without a diagnosis of obesity had similar findings.
"Although our results may be consistent with the hypothesis that semaglutide might be beneficial for smoking cessation, study limitations preclude firm conclusions and should not be interpreted to justify clinicians' use of semaglutide off-label for smoking cessation," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-30 07:15
Read more
- Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints
- Beta Blockers Unnecessary for Folks Without Heart Failure; May Be Linked to Depression
- AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia
- Winter's Onset Brings Mood Changes to Many Americans, Poll Finds
- Reducing Sedentary Time, Increasing Standing Does Not Reduce BP
- Psychedelics Like Psilocybin, MDMA Tied to Higher Odds for Schizophrenia
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions